Cargando…
CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer
Breast cancer (BC) is one of the most common malignant cancers in females worldwide and greatly threatens women's health. The C-type lectin domain family 10 member A (CLEC10A) is a member of the C-type lectin receptor family that has been previously reported to promote the antitumor activity of...
Autores principales: | Tang, Shasha, Zhang, Yi, Lin, Xiaoyan, Wang, Hui, Yong, Liyun, Zhang, Hongyi, Cai, Fengfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260715/ https://www.ncbi.nlm.nih.gov/pubmed/35814828 http://dx.doi.org/10.3892/ol.2022.13405 |
Ejemplares similares
-
CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma
por: He, Min, et al.
Publicado: (2021) -
Low expression of HIF1AN accompanied by less immune infiltration is associated with poor prognosis in breast cancer
por: Tang, Shasha, et al.
Publicado: (2023) -
Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast
por: Zhang, Hongyi, et al.
Publicado: (2022) -
Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists
por: Clark, Joanne C., et al.
Publicado: (2023) -
CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Liang, Xiaoliang, et al.
Publicado: (2022)